2021
DOI: 10.11607/prd.5665
|View full text |Cite
|
Sign up to set email alerts
|

The Use of a Collagen Scaffold to Augment Buccal Ridge Contour Concurrently with Implant Placement: A Two-Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Further, it was mentioned that BMPs are expensive and thus cost-benefit needs to be considered in the decision-making process (11). Regarding soft tissue grafts, in addition to autografts, some clinicians use collagen-based membranes (12) along with rhPDGF or EMD to promote cell migration and proliferation in addition to vascular infiltration, as reported in the literature (3). More recently, two of the clinicians (MF and IP) have been using amnion-chorion grafts (13), which are known to be rich in biological factors and also reported to be antimicrobial, with some positive results to date (14)(15)(16)(17)(18).…”
Section: Name Current Positions Backgroundmentioning
confidence: 99%
See 1 more Smart Citation
“…Further, it was mentioned that BMPs are expensive and thus cost-benefit needs to be considered in the decision-making process (11). Regarding soft tissue grafts, in addition to autografts, some clinicians use collagen-based membranes (12) along with rhPDGF or EMD to promote cell migration and proliferation in addition to vascular infiltration, as reported in the literature (3). More recently, two of the clinicians (MF and IP) have been using amnion-chorion grafts (13), which are known to be rich in biological factors and also reported to be antimicrobial, with some positive results to date (14)(15)(16)(17)(18).…”
Section: Name Current Positions Backgroundmentioning
confidence: 99%
“…As stated above, biologics and scaffolds are routinely used in clinical practice. Biologics used that were mentioned during our (12)(13)(14)(15)(16). It is important to note that the regulatory agencies in Europe are restrictive on the use of biologics and allografts, and differences between EU countries exist, making it difficult for clinicians to use many of these materials across Europe (36).…”
Section: Do You Feel That Existing Regenerative Approaches Have Robus...mentioning
confidence: 99%